Prognostic Value of Serum IL-10 and Soluble IL-2 Receptor Level in Aggressive Non-Hodgkin's Lymphomas
نویسندگان
چکیده
Although, there has been a dramatic improvement in the ability to therapeutically alter the course of this malignancy, a substantial proportion of patients may either not respond to treatment or experience relapse and eventually die of progressive disease that is not sensitive to further chemotherapy [1] underscoring the need of more accurate methods of prospectively identifying patients with different long term prognosis.
منابع مشابه
Detection of IL-4, IL-6 and IL-12 Serum Levels in Generalized Aggressive Periodontitis
Background: Periodontitis is a multifactorial chronic inflammatory disease characterized by destruction of tooth-supporting tissues. Environmental and genetic factors as well as the immune system participate in this process. Recent studies have attempted to elucidate the role of cytokine networks involved in periodontal diseases. Objective: To assess and compare the levels of IL-4, IL-6 and IL-...
متن کاملSerum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma.
Acute lymphoblastic leukaemia/lymphoma (ALL/LBL) is an aggressive form of non-Hodgkin's lymphoma (NHL) affecting B-cells or T-cells, respectively. The serum level of soluble interleukin-2 receptor (sIL-2R) is known to reflect the immune activity and tumour volume in aggressive NHL; however, the release of sIL-2R in LBL has not been extensively studied. Further, the relationship between sIL-2R r...
متن کاملBcr-Abl adds another twist to cell fate.
(ie, IL-15) and growth signals clearly play a role in T-cell proliferation and function. 7 Finally, in its effort to answer a very specific question regarding the role of sIL-2R␣, the present article is not able to address the malignant lymphoma B-cell population itself and how it interacts with intratumoral T cells. Nevertheless, this report by Yang and colleagues is the first to describe the ...
متن کاملIdentification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas.
The molecular basis of neoplastic B-cell growth is complex and poorly understood. Cytokines have been postulated to contribute to neoplastic cell growth, and many in vitro studies have confirmed this prediction, but little is known about the in vivo role of these growth factors. We have examined the production of interleukin-14 (IL-14) (high molecular weight [HMW], B-cell growth factor [BCGF]) ...
متن کاملSerum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.
Advances in chemotherapy have led to a favorable long-term prognosis in approximately 50% of patients with aggressive non-Hodgkin lymphoma (NHL). However, the remaining patients do not enjoy such prolonged survival after standard treatment. New prognostic factors are needed to define this poor-prognosis group and to plan an appropriate treatment strategy. It has been reported that serum nm23-H1...
متن کامل